Table 3.

Pooled prevalence of Multidrug Resistance of E. coli, Klebsiella spp and Staphylococcus spp- based on meta-analysis of human studies with respect to study area

Bacteria mostly reported in studies	Study Area (Region)	Number of studies	Pooled prevalence of AMR (95% CI)	p value
E. coli	Centre	6	35.9 (24.2–49.6)	0.25
	South-West	3	45.6 (35.6–56.0)	0.82
	North-West	3	60.9 (33.0–83.2)	0.33
	West	3	40.9 (28.1–55.0)	0.61
Klebsiella spp	Centre	4	45.8 (28.3–64.1)	0.65
	South-West	4	51.6 (38.5–64.5)	0.82
	North-West	2	52.6 (30.5–73.7)	0.64
	West	2	57.9 (47.7–67.4)	0.13
Staphylococcus spp	Centre	5	39.2 (23.2–57.8)	0.45
	South-West	2	62.2 (18.2–92.4)	0.20
	North-West	5	45.3 (36.2–54.7)	0.69
	West	4	56.6 (32.0–78.4)	0.45

Note: P values are from random effects analysis, AMR: Antimicrobial resistance